CellaVision AB (publ)

OM:CEVI Stock Report

Market Cap: SEK 3.6b

CellaVision Past Earnings Performance

Past criteria checks 3/6

CellaVision has been growing earnings at an average annual rate of 9%, while the Medical Equipment industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 9.8% per year. CellaVision's return on equity is 17.3%, and it has net margins of 19.5%.

Key information

9.0%

Earnings growth rate

9.0%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate9.8%
Return on equity17.3%
Net Margin19.5%
Next Earnings Update29 Apr 2025

Recent past performance updates

Recent updates

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.50

Apr 03
CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.50
author-image

Next-generation Digital Cell Morphology Analyzer Will Drive Future Product Development

Feb 13 Strategic alignment with Sysmex and innovation are driving growth, enhancing revenue and future earnings potential.

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.50

Feb 11
CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.50

Analyst Estimates: Here's What Brokers Think Of CellaVision AB (publ) (STO:CEVI) After Its Annual Report

Feb 10
Analyst Estimates: Here's What Brokers Think Of CellaVision AB (publ) (STO:CEVI) After Its Annual Report

CellaVision AB (publ)'s (STO:CEVI) Share Price Could Signal Some Risk

Feb 08
CellaVision AB (publ)'s (STO:CEVI) Share Price Could Signal Some Risk

Is Now The Time To Put CellaVision (STO:CEVI) On Your Watchlist?

Jan 21
Is Now The Time To Put CellaVision (STO:CEVI) On Your Watchlist?

Does CellaVision (STO:CEVI) Have A Healthy Balance Sheet?

Nov 20
Does CellaVision (STO:CEVI) Have A Healthy Balance Sheet?

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 27
CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 24
CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is CellaVision (STO:CEVI) A Risky Investment?

Jun 07
Is CellaVision (STO:CEVI) A Risky Investment?

Does CellaVision (STO:CEVI) Deserve A Spot On Your Watchlist?

May 22
Does CellaVision (STO:CEVI) Deserve A Spot On Your Watchlist?

CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25

Apr 13
CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25

CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

Apr 09
CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Mar 28
CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

Mar 14
CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 29
CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

Feb 16
After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 12
CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 10
Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Dec 13
CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Sep 14
Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 22
Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

Jun 17
CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

May 07
CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

Apr 19
Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

Apr 05
CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

Mar 04
CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Feb 11
CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Is CellaVision (STO:CEVI) A Risky Investment?

Jan 13
Is CellaVision (STO:CEVI) A Risky Investment?

Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

Dec 13
Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

Revenue & Expenses Breakdown

How CellaVision makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OM:CEVI Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2472314122287
30 Sep 2473715021986
30 Jun 2472614521783
31 Mar 2470814121384
31 Dec 2367713021383
30 Sep 2362911220283
30 Jun 236029719691
31 Mar 236169919691
31 Dec 2263911819189
30 Sep 2265112619486
30 Jun 2264214218672
31 Mar 2259413517467
31 Dec 2156612516564
30 Sep 2153211416061
30 Jun 2148810115054
31 Mar 214719814752
31 Dec 204718915251
30 Sep 204908515954
30 Jun 204988916559
31 Mar 204929216360
31 Dec 194629915056
30 Sep 1942310413553
30 Jun 1941210413148
31 Mar 193919712443
31 Dec 183658912039
30 Sep 183307611433
30 Jun 183076710930
31 Mar 182946310627
31 Dec 173097010627
30 Sep 173067010128
30 Jun 17313789728
31 Mar 17300759230
31 Dec 16265608629
30 Sep 16254578529
30 Jun 16260668227
31 Mar 16246558228
31 Dec 15239538227
30 Sep 15250498429
30 Jun 15223308228
31 Mar 15226348325
31 Dec 14217318023
30 Sep 14209337319
30 Jun 14207367017

Quality Earnings: CEVI has high quality earnings.

Growing Profit Margin: CEVI's current net profit margins (19.5%) are higher than last year (19.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CEVI's earnings have grown by 9% per year over the past 5 years.

Accelerating Growth: CEVI's earnings growth over the past year (8%) is below its 5-year average (9% per year).

Earnings vs Industry: CEVI earnings growth over the past year (8%) did not outperform the Medical Equipment industry 56.5%.

Return on Equity

High ROE: CEVI's Return on Equity (17.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/17 17:39
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CellaVision AB (publ) is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sten GustafssonABG Sundal Collier
Bjorn RydellABG Sundal Collier Sponsored
Carl-Oscar BredengenBerenberg